Literature DB >> 9085111

Expression of vascular endothelial growth factor in experimental choroidal neovascularization.

T Ishibashi1, Y Hata, H Yoshikawa, K Nakagawa, K Sueishi, H Inomata.   

Abstract

BACKGROUND: Although the choroidal neovascularization (CNV) is a common pathologic feature of a number of different eye diseases, its pathological mechanisms have not been fully elucidated. We investigated the expression of vascular endothelial growth factor (VEGF) in CNV using an experimental primate model.
METHOD: CNV was induced by intense laser photocoagulation in four monkey eyes. Single eyes were enucleated at 1, 3, 7 or 14 days after photocoagulation and examined immunohistochemically for VEGF, macrophage antigen, von Willebrand factor and glial fibrillary acidic protein (GFAP). Expression of VEGF mRNA was examined by in situ hybridization.
RESULTS: One day after photocoagulation, the normal structure of the outer portion of the retina and the inner portion of the choroid was destroyed. Three days after photocoagulation, choroidal vascular endothelial cells migrated into the subretinal space through the defect in Bruch's membrane. Increased expression of VEGF was detected in the accumulating macrophages, migrating retinal pigment epithelial (RPE) cells and Müller cells. Maximal expression of VEGF was observed between 3 and 7 days after wounding, and many newly formed vessels extended into the subretinal space 7-14 days after photocoagulation.
CONCLUSION: VEGF derived from RPE cells, macrophages and Müller cells may play a role in the formation of CNV.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085111     DOI: 10.1007/bf00941723

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  41 in total

1.  A clinical study of the vascularity of senile disciform macular degeneration.

Authors:  V W Teeters; A C Bird
Journal:  Am J Ophthalmol       Date:  1973-01       Impact factor: 5.258

2.  Electron microscopic features of experimental choroidal neovascularization.

Authors:  D B Archer; T A Gardiner
Journal:  Am J Ophthalmol       Date:  1981-04       Impact factor: 5.258

3.  Subretinal neovascularization. Natural history of an experimental model.

Authors:  S J Ryan
Journal:  Arch Ophthalmol       Date:  1982-11

4.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Authors:  N Ferrara; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

5.  Changes in intermediate filament immunolabeling occur in response to retinal detachment and reattachment in primates.

Authors:  C J Guérin; D H Anderson; S K Fisher
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-08       Impact factor: 4.799

6.  Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.

Authors:  H Shen; M Clauss; J Ryan; A M Schmidt; P Tijburg; L Borden; D Connolly; D Stern; J Kao
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

7.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

Authors:  E A Pierce; R L Avery; E D Foley; L P Aiello; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

8.  Factor VII related antigen as an endothelial cell marker in benign and malignant diseases.

Authors:  M Sehested; K Hou-Jensen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

9.  Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells.

Authors:  A P Adamis; D T Shima; K T Yeo; T K Yeo; L F Brown; B Berse; P A D'Amore; J Folkman
Journal:  Biochem Biophys Res Commun       Date:  1993-06-15       Impact factor: 3.575

10.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

Authors:  M Clauss; M Gerlach; H Gerlach; J Brett; F Wang; P C Familletti; Y C Pan; J V Olander; D T Connolly; D Stern
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  70 in total

1.  Dynamics of phosphorothioate oligonucleotides in normal and laser photocoagulated retina.

Authors:  W Y Shen; K L Garrett; L da Cruz; I J Constable; P E Rakoczy
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

2.  Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.

Authors:  Atsunobu Takeda; Yasuaki Hata; Satomi Shiose; Yukio Sassa; Masae Honda; Kimihiko Fujisawa; Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-23       Impact factor: 3.117

3.  Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.

Authors:  Kyoungmin Park; Ji Jin; Yang Hu; Kevin Zhou; Jian-xing Ma
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 4.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

5.  Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat.

Authors:  W Y Shen; M J Yu; C J Barry; I J Constable; P E Rakoczy
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

6.  Genetic loci that control the size of laser-induced choroidal neovascularization.

Authors:  Kei Nakai; Michael S Rogers; Takashi Baba; Taisaku Funakoshi; Amy E Birsner; Dema S Luyindula; Robert J D'Amato
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

Review 7.  Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

Authors:  Claudio Campa; Ciro Costagliola; Carlo Incorvaia; Carl Sheridan; Francesco Semeraro; Katia De Nadai; Adolfo Sebastiani; Francesco Parmeggiani
Journal:  Mediators Inflamm       Date:  2010-08-25       Impact factor: 4.711

8.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

9.  Fibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGF.

Authors:  Satomi Shiose; Yasuaki Hata; Yoshihiro Noda; Yukio Sassa; Atsunobu Takeda; Hiroshi Yoshikawa; Kimihiko Fujisawa; Toshiaki Kubota; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

Review 10.  Angiogenesis in eye disease: immunity gained or immunity lost?

Authors:  Thomas A Ferguson; Rajendra S Apte
Journal:  Semin Immunopathol       Date:  2008-02-23       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.